These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3489648)

  • 41. Comparison of in vitro activities of eight new beta-lactam compounds against cephalothin-resistant Enterobacteriaceae from hospital patients.
    Costopoulos C; Legakis NJ; Papafragas E; Marinis E
    Chemotherapy; 1984; 30(3):158-64. PubMed ID: 6610538
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of agar dilution, identification of beta-lactamases and disc diffusion methods for assessing the sensitivity to ticarcillin-clavulanic acid.
    Joly B; Chanal M; Sirot D; Cluzel M; Sirot J; Cluzel R
    J Antimicrob Chemother; 1986 May; 17 Suppl C():27-33. PubMed ID: 3522530
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clavulanate and beta-lactamase induction.
    Livermore DM; Akova M; Wu PJ; Yang YJ
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():23-33. PubMed ID: 2606817
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.
    Stürenburg E; Sobottka I; Noor D; Laufs R; Mack D
    J Antimicrob Chemother; 2004 Jul; 54(1):134-8. PubMed ID: 15150168
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Urinary tract infections in children. Status in a pediatric hospital and sensitivity of bacterial strains to amoxycillin-clavulanic acid combination].
    Cochat N; Barbe G; Boutin-Tranchant ME; Cochat P
    Pediatrie; 1987; 42(4):309-14. PubMed ID: 3671031
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
    Monteil H; Jehl F
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):805-8. PubMed ID: 3309818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Distribution of constituent beta-lactamases in Pseudomonas aeruginosa].
    Philippon A; Thabaut A; Meyran M; Nevot P
    Presse Med; 1984 Mar; 13(13):772-6. PubMed ID: 6231593
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Activity of ticarcillin combined with different concentrations of clavulanic acid on 137 Gram-negative bacilli resistant to ticarcillin].
    Aubert G; Dorche G; Frere A; Raby N; Denis M
    Pathol Biol (Paris); 1987 May; 35(5):537-41. PubMed ID: 3302858
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Fluoroquinolone and aminoglycoside resistance in chromosomal cephalosporinase-overproducing gram-negative bacilli strains with inducible beta-lactamase].
    López-Yeste M; Xercavins M; Lite J; Cuchí E; Garau J
    Enferm Infecc Microbiol Clin; 1996 Apr; 14(4):211-4. PubMed ID: 9044634
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The activity of a sulphone beta-lactamase inhibitor, YTR 830.
    Moosdeen F; Williams J; Yamabe S
    Chemioterapia; 1987 Jun; 6(2 Suppl):206-7. PubMed ID: 2855613
    [No Abstract]   [Full Text] [Related]  

  • 52. Overcoming Beta-Lactamase-Based Antimicrobial Resistance by Nanocarrier-Loaded Clavulanic Acid and Antibiotic Cotreatments.
    Filby BW; Weldrick PJ; Paunov VN
    ACS Appl Bio Mater; 2022 Aug; 5(8):3826-3840. PubMed ID: 35819369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro activity of mecillinam and amoxicillin/clavulanic acid against strains of Escherichia coli producing TEM-1, Oxa-1 and chromosomal beta-lactamases.
    Marre R; Schulz E
    Arzneimittelforschung; 1988 Jul; 38(7):863-5. PubMed ID: 3061383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of a ticarcillin-clavulanic acid (timentin) combination on bacteria resistant to ticarcillin].
    Rouhan D; Le Noc P; Robert J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):461-5. PubMed ID: 3937121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide.
    Drieux L; Brossier F; Sougakoff W; Jarlier V
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():90-103. PubMed ID: 18154532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of beta-lactamase production and enzyme profiles in Enterobacteriaceae isolated in Moldova.
    Poiată A; Gheorghiu R; Diculencu D; Bosnea D; Păduraru O; Constantiniu S; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 1993; 97(1):429-32. PubMed ID: 8153468
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae.
    Ku YH; Chuang YC; Yu WL
    J Microbiol Immunol Infect; 2008 Aug; 41(4):332-6. PubMed ID: 18787741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potentiation of human polymorphonuclear leukocyte phagocytosis and intracellular bactericidal activity by amoxycillin/clavulanic acid.
    Cuffini AM; De Renzi G; Tullio V; Paizis G; Carlone NA
    Drugs Exp Clin Res; 1996; 22(1):9-15. PubMed ID: 8839632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests.
    Sanders CC; Iaconis JP; Bodey GP; Samonis G
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1365-9. PubMed ID: 3143303
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro-activity of clavulanic acid and amoxicillin combined against amoxicillin-resistant bacteria.
    Peters G; Pulverer G; Neugebauer M
    Infection; 1980; 8(3):104-6. PubMed ID: 6903180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.